In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Standard BioTools Inc’s stock clocked out at $1.16, down -0.85% from its previous closing price of $1.17. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 1.39 million shares were traded. LAB stock price reached its highest trading level at $1.17 during the session, while it also had its lowest trading level at $1.11.
Ratios:
To gain a deeper understanding of LAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 16, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $3.50.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.Jefferies initiated its Buy rating on April 04, 2024, with a $3.25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 28 ’25 when Casdin Partners Master Fund, L bought 4,820,959 shares for $1.06 per share. The transaction valued at 5,134,321 led to the insider holds 58,846,780 shares of the business.
Black Jeffrey G. bought 57,971 shares of LAB for $123,098 on Nov 12 ’24. On Sep 09 ’24, another insider, Taich Adam, who serves as the Former Officer of the company, bought 45,851 shares for $2.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 443413472 and an Enterprise Value of 172113312. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.52 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 0.987 whereas that against EBITDA is -1.46.
Stock Price History:
The Beta on a monthly basis for LAB is 1.51, which has changed by -0.55725193 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, LAB has reached a high of $3.04, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -19.51%, while the 200-Day Moving Average is calculated to be -36.27%.
Shares Statistics:
It appears that LAB traded 1.97M shares on average per day over the past three months and 1735180 shares per day over the past ten days. A total of 377.53M shares are outstanding, with a floating share count of 366.94M. Insiders hold about 3.18% of the company’s shares, while institutions hold 73.62% stake in the company. Shares short for LAB as of 1740700800 were 14165972 with a Short Ratio of 7.20, compared to 1738281600 on 12849731. Therefore, it implies a Short% of Shares Outstanding of 14165972 and a Short% of Float of 7.8099996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
